✦ LIBER ✦

Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin

✍ Scribed by Paul J. Thuluvath; Hemant Pande; Joyce Maygers

Book ID: 110420986
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 29 KB
Volume: 48
Category: Article
ISSN: 0163-2116
DOI: 10.1023/a:1022509304694

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of interferon and ribavirin

Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon

✍ Adrian M. Di Bisceglie; Judy Thompson; Nancy Smith-Wilkaitis; Elizabeth M. Brunt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Merimepodib, pegylated interferon, and r

Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a

r-interferon alfa–2b/ribavirin combined

r-interferon alfa–2b/ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C interferon nonresponders

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Combination of interferon induction ther

Combination of interferon induction therapy and ribavirin in chronic hepatitis C

✍ Peter Ferenci; Harald Brunner; Karin Nachbaur; Christian Datz; Michael Gschwantl 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Combination therapy with interferon-α an

Combination therapy with interferon-α and ribavirin as immunomodulators in patients with chronic hepatitis C

✍ Norio Horiike; Morikazu Onji 📂 Article 📅 2003 🏛 Springer Japan 🌐 English ⚖ 132 KB